Tag Archives: health-insurance

4 Funds To Buy On Healthy Medical Sector Earnings

Ongoing worries, including weak global growth, strengthening dollar and the persistent slump in oil price, appear to have affected Q4 corporate earnings. Amid this dismal backdrop, the medical sector has emerged as one of the few bright spots. And the sector’s outlook for the coming quarters also looks impressive. As such, fundamentally strong funds from this sector may offer favorable investment propositions. Medical Sector Outperforms Total earnings of the 388 S&P 500 members that reported Q4 results as of Feb 17 declined 6.4% year over year on 4.6% lower revenues. And nine out of the 16 Zacks sectors are expected to suffer an earnings decline in their Q4 results. Total earnings for the S&P 500 members are expected to decline 6.7% year over year. In spite of the overall softness, companies from the medical sector that have reported as of Feb. 17 registered total earnings growth of 7.4% on 9.1% higher revenues. The sector is expected to witness earnings growth of 9.2% on 9.4% higher revenues for the quarter. Earnings and revenues for the sector are also expected to grow in 2016. For the ongoing quarter, the sector is predicted to register earnings and revenue growth of 3.8% and 8.4%, respectively. Some of the major players from this sector including Regeneron Pharmaceuticals (NASDAQ: REGN ), UnitedHealth Group Inc. (NYSE: UNH ) and Gilead Sciences, Inc. (NASDAQ: GILD ) posted impressive results for the fourth quarter. What Will Boost Medical Sector in 2016? The Affordable Care Act (ACA) is likely to play an important role in boosting the healthcare sector this year. With a gradual decline in the unemployment rate and healthy job additions over the past few months, new employees should widen the coverage of health insurance and perk up demand in the sector. Moreover, government spending on healthcare is also expected to rise nearly 4.9% this year. It is estimated that Medicare and Medicaid spending may increase to over $1.25 trillion in 2016. Further, merger and acquisition activities in the broader medical sector are expected to remain strong in 2016 and be significant catalysts to the sector’s growth. Separately, advancement in technology and innovation should also bode well for the space. Advances in genomics, biotechnology and artificial intelligence have not only helped the sector to grow over the past few years, but are also likely to be the growth drivers in the years to come. 4 Funds to Consider Given these encouraging earnings performance and promising outlook, we present four healthcare mutual funds that are significantly exposed to medical sector and carry either a Zacks Mutual Fund Rank #1 (Strong Buy) or #2 (Buy). We expect these funds to outperform their peers in the near future. Remember, the goal of the Zacks Mutual Fund Rank is to guide investors to identify potential winners and losers. Unlike most of the fund-rating systems, the Zacks Mutual Fund Rank is not just focused on past performance, but also on the likely future success of the fund. These funds have strong three- and five-year annualized returns. The minimum initial investment is within $5000. Also, these funds have a low expense ratio and no sales load. T. Rowe Price Health Sciences (MUTF: PRHSX ) invests a major portion of its assets in common stocks of companies whose primary operations are related to health sciences. The fund focuses on investing in large- and mid-cap firms. PRHSX currently carries a Zacks Mutual Fund Rank #1 and has three- and five-year annualized returns of 20.6% and 21.2%, respectively. The annual expense ratio of 0.77% is lower than the category average of 1.36%. Fidelity Select Medical Equipment & Systems (MUTF: FSMEX ) seeks growth of capital. The fund invests the lion’s share of its assets in companies that are primarily involved in operations related to medical equipment and devices and the related technologies sector. The fund focuses on acquiring common stocks of both U.S. and non-U.S. companies. FSMEX currently carries a Zacks Mutual Fund Rank #1 and has three- and five-year annualized returns of 16.3% and 12.7%, respectively. The annual expense ratio of 0.77% is lower than the category average of 1.36%. Hartford Healthcare HLS IA (MUTF: HIAHX ) invests most of its assets in equities of healthcare-related companies of any size across the globe. The sub-adviser selects the equity securities and the issuers may be from other countries, including the U.S. cash balances of HIAHX are not expected to be more than 10% of its assets. HIAHX currently carries a Zacks Mutual Fund Rank #1 and has three- and five-year annualized returns of 18% and 17.4%, respectively. The annual expense ratio of 0.88% is lower than the category average of 1.36%. Fidelity Select Health Care Portfolio (MUTF: FSPHX ) seeks capital growth over the long run. The fund invests a major portion of its assets in companies involved in designing, manufacturing and selling healthcare products and services. The fund invests in companies across the world. FSPHX currently carries a Zacks Mutual Fund Rank #2 and has three- and five-year annualized returns of 21.2% and 18.2%, respectively. The annual expense ratio of 0.74% is lower than the category average of 1.36%.

Insurance ETFs Benefiting From Decent Q4 Earnings

Though the financial sector has been on a rough ride this year, especially on plunging oil prices, global growth concerns and reduced likelihood of frequent interest rate hikes, Q4 earnings are faring well so far. Total earnings for 77.9% of the sector’s total market capitalization are up 5.3% on 0.7% higher revenues. This is better than earnings growth of 3.6% and revenue decline of 1.3% for the group of the same companies reported in Q3. As much as 66.2% of the companies beat earnings estimates and 60.8% beat on the top line compared with earnings and revenue beat ratios of 55.4% and 44.6%, respectively in Q3. In particular, earnings from the insurance industry have been strong with most players managing to beat either our earnings or revenue estimates. Earnings at Chubb Corp (NYSE: CB ) surpassed our estimates while Prudential Financial (NYSE: PRU ) and American International (NYSE: AIG ) topped revenues. Aflac Inc. (NYSE: AFL ), Allstate (NYSE: ALL ) and Travelers (NYSE: TRV ) surpassed our estimates for both the top and the bottom lines while MetLife (NYSE: MET ) missed on both (read: Buy the Dip in These Undervalued Sector ETFs & Stocks ). Insurance Earnings in Focus Earnings at one of the leading property and casualty insurer – Chubb – outpaced our estimate by 4.39% but decreased 3.6% from the year-ago quarter. However, revenues of $4.73 billion missed the Zacks Consensus Estimate of $4.77 billion. Another property and casualty insurer and an industry bellwether, Allstate , topped the Zacks Consensus Estimate by 27 cents reporting earnings of $1.60, which declined 7% from the year-ago quarter. Revenues declined 0.8% year over year to $8.94 billion and edged past the Zacks Consensus Estimate of $8.01 billion. Aflac , the seller of supplement health insurance, posted earnings per share of $1.56, beating our estimate by 8 cents and improving 20.9% year over year. Revenues declined 3.5% year over year to $5.32 billion but were ahead of our estimate of $5.24 billion. Earnings of $2.93 per share reported by personal property and casualty insurer Travelers trumped the Zacks Consensus Estimate by 19 cents but decreased 6% from the year-ago quarter. Revenues slid 2% year over year to $6.7 billion and were well ahead of our estimate of $6.63 billion. However, MetLife , the U.S. life insurer behemoth, reported disappointing earnings of $1.23 per share, which lagged the Zacks Consensus Estimate of $1.36 and declined 11% from the year-ago quarter. Revenues also fell 6% year over year to $17.11 billion and were well below our estimated $17.45 billion. On the other hand, PRU , the second-largest U.S. life insurer, also missed our earnings estimate by a huge 33 cents and declined 8.5% year over year. Revenues plunged 16.3% year over year to $13.2 billion but surpassed our estimate of $11.6 billion. The largest commercial insurer in the U.S. and Canada, AIG lagged the earnings estimate but beat on revenues. Loss per share of $1.10 is wider than the Zacks Consensus Estimate of a loss of 90 cents. In the year-ago quarter, the company had reported earnings of 97 cents per share. However, revenues of $13.49 billion came above our estimate of $12.84 billion. ETFs in Focus Given decent Q4 earnings, insurance ETFs have fared well, losing less than the other corners of the financial space from a one-month look. This is especially true as these funds lost in the range of 2.5-4% compared to the loss of 6.5% for the Financial Select Sector SPDR ETF (NYSEARCA: XLF ) and 8% for the SPDR S&P Bank ETF (NYSEARCA: KBE ) . Investors looking to gain exposure to the insurance corner of the market segment in a diversified way may consider the following ETFs. SPDR S&P Insurance ETF (NYSEARCA: KIE ) This fund follows the S&P Insurance Select Industry Index and offers an equal weight exposure to 49 stocks, suggesting no concentration risk. None of the securities holds more than 2.61% of total assets. More than one-third of the portfolio is allocated to the property and casualty insurance sector while life & health insurance accounts for 21.4% share. The ETF has managed $412.7 million in its asset base and trades in a moderate average daily volume of about 134,000 shares. The product has an expense ratio of 0.35% and lost nearly 2.5% over the past one month. It has a Zacks ETF Rank of 3 or ‘Hold’ rating with a Medium risk outlook. iShares U.S. Insurance ETF (NYSEARCA: IAK ) With AUM of $97.3 million, this product tracks the Dow Jones U.S. Select Insurance Index and charges 44 bps in annual fees. Volume is light, trading in roughly 31,000 shares per day. In total, the fund holds 61 securities in its basket with the largest allocation going to American International at 12.1%, closely followed by Chubb at 10.4%. Other firms hold less than 7.8% of assets. From an industry look, property & casualty insurance accounts for 46.7% share while life & health insurance and multiline insurance round off the top three with double-digit exposure each. IAK is down 3.8% from a one-month look and has a Zacks ETF Rank of 3 with a Medium risk outlook. PowerShares KBW Insurance Fund (NYSEARCA: KBWI ) This fund tracks the KBW Nasdaq Insurance Index and holds 24 securities in its basket. Each firm holds less than 8.8% share with TRV, AIG, MET, PRU and ALL being among the top 10 holdings. While insurance makes up for 96% of the portfolio, consumer finance and banks take the remainder. The product has amassed about $11.9 million in AUM while volume is paltry with about 1,000 shares exchanging hands a day. The ETF charges an annual fee of 35 bps and shed 3.5% in the trailing one-month period. It has a Zacks ETF Rank of 3 with a High risk outlook. Link to the original post on Zacks.com

Innovation And Scotch Tape

Summary We think too many investors put too much stock into being “first movers.” We use research from HBR to show how calm waters and scotch tape can lay the foundation for solid portfolios. We prefer building a portfolio by investing in companies with large moats using a calm waters approach. In business and economics, a “first-mover advantage” is defined as the benefit accrued to a company whose product is the first to enter a market. These products often create or define an entirely new market opportunity that the world hadn’t known before. Some “first-mover” examples have created very attractive long-duration opportunities. eBAY (NASDAQ: EBAY ), a company we own in our portfolios, was the first online auction service. It has maintained leadership in that area for the last two decades. Kleenex (NYSE: KMB ) was a first mover in the facial tissues market, and has become so common that most people don’t know what a facial tissue is without saying the product name. A prime first-mover example is Coca-Cola (NYSE: KO ), which created the soda pop market in 1896 and continues to dominate it 120 years later. Examples like these give credence to the idea that the early bird indeed catches the worm. The notion has become more powerful as you consider the massive ego and financial benefits of being the next Elon Musk or Jeff Bezos. The possibility of relatively immediate notoriety and wealth has not been lost on private equity investors. It is estimated that private equity firms sit on more than $1.2 trillion of cash that is waiting in the wings to find those kinds of attractive targets. When looking at the cash plus advantage that private equity firms can apply towards deal-making, it has never been higher than today. The private equity deals of today are done at very rich multiples. EBITDA and net income multiples of 6x and 21x higher than the S&P 500 are typical. All this sounds very exciting to us. It brings to mind something Warren Buffett says, “Investors should remember that excitement and expense are their enemies.” At Smead Capital Management, we like companies which have a long history of profitability and strong operating metrics. With very few exceptions, we will not consider a company for which we can’t find at least 7-10 years of history in the public markets. We like businesses that have very wide moats (defensible positions) around their products and services. We like products that are so ubiquitous that they are associated with categories or industries. We think Aflac (NYSE: AFL ), H&R Block (NYSE: HRB ), and Disney (NYSE: DIS ) are nearly inseparable to concepts like supplemental health insurance, taxes, and wholesome family entertainment. Creating brand identity and awareness of this sort translate to very strong and durational business value. We know this sounds substantially more boring than what goes through the blood of those who believe there’s “gold in them thar hills.” There may be gold, but most of the real-world stories told around the campfire of first movers are laden with pain and destruction. After all, was it really helpful to be the first mover in online search (AltaVista / Infoseek), videotape (Betamax), cellular phones (BlackBerry (NASDAQ: BBRY ) / Motorola (NYSE: MSI )), social networking (MySpace), new grocery delivery systems (Webvan), or new and innovative ways of transportation (Segway)? Especially in a world where most innovation efforts are geared towards the technology sector, an area that can be defined by disruptive innovation, we at Smead Capital Management don’t think so. What we find exciting is attempting to understand how our portfolio of companies may be able to leverage brands and products using newer technologies that will extend awareness and increase interaction. What kind of probability can we assign to the success of our companies gaining meaningful leverage from modern-day innovation? A Harvard Business Review article by Fernando Suarez and Gianvito Lanzolla gave us a very helpful framework to think about the concept of technological changes in relation to market development. Suarez and Lanzolla argue that maintaining a long-lasting dominant position is most probable if the market and technological evolution is slow and stable. They use Scotch Tape as an example of “calm waters,” where being first to market has a high likelihood of durability. For calm-water situations, even if technological innovation is attainable, the advantage is not large enough to disrupt or dislocate the core value proposition. The appeal and adoption of calm-water products is also very gradual, giving ample time to organize production, distribution, and branding. Scotch Tape was originally intended for industrial use, and as the product developed just prior to the Great Depression, became widely used by individuals looking to repair household items that might otherwise be discarded. Its parent company, 3M (NYSE: MMM ), had plenty of time to build a strong and wide moat before full market adoption. Nordstrom (NYSE: JWN ) began in 1901 as a humble shoe store, and began selling apparel in the early 1960s. Starbucks (NASDAQ: SBUX ) has been selling an addictive legal drug for over 40 years, and H&R Block began its campaign towards dominating the world of tax services just after WWII. Gannett (NYSE: GCI ) and News Corporation (NASDAQ: NWSA ) operate media franchises whose brands have been around for decades. Experts who are the most excited about the evolution of technology think these brands have far less relevance in an on-demand era driven by digitization. We think these are examples of calm-water situations. The moats are very large, and the products and services have been developed over many years. The possibilities for innovative disruption are real, but in our opinion, far less likely to interrupt the value proposition of the brands themselves. We think we can assign a reasonably high probability of success as these companies utilize innovation to extend brand awareness and reach. Nordstrom’s Direct (online) business has mushroomed from less than $500 million in 2006 to nearly $2 billion last year, but management speaks of this as just one important piece of the company’s larger omni-channel strategy. It’s very complimentary to the core proposition, and greatly leverages what Nordstrom has done extraordinarily well for years. Starbucks has greatly enhanced the experience of its customers through innovation as well. Gannett and News Corporation are dealing with the challenge of applying technology to its core content offerings, causing the stocks to trade at deep discounts to intrinsic value. We believe they are very well positioned to leverage their brands in the digital world. News Corporation, with waterfront property brands like the Wall Street Journal and Barron’s (whose subscriber bases continue to grow), has highlighted the success it is having with digital migration in recent earnings calls. Similarly, we believe the content Gannett provides with its 5,000+ journalists will be relevant for years to come, and is set up to extend the company’s brands digitally. Calm-water situations provide an essential buffer for a company to positively leverage the technological evolution, not be displaced by it. A wide moat affords a company the time necessary to properly assess the best strategy to position itself in new channels and venues. At Smead Capital Management, we don’t expect our companies to win every battle. We are very optimistic about how our companies are positioned to win wars even as evolutionary change presents itself. The information contained in this missive represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results. Tony Scherrer, CFA, Director of Research, wrote this article. It should not be assumed that investing in any securities mentioned above will or will not be profitable. A list of all recommendations made by Smead Capital Management within the past twelve month period is available upon request.